AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajanayagam, V.
Right arrow Articles by Stillman, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajanayagam, V.
Right arrow Articles by Stillman, A. E.

American Journal of Neuroradiology, Vol 17, Issue 6 1013-1024, Copyright © 1996 by American Society of Neuroradiology


ARTICLES

Proton MR spectroscopy of childhood adrenoleukodystrophy

V Rajanayagam, J Grad, W Krivit, DJ Loes, L Lockman, E Shapiro, M Balthazor, D Aeppli and AE Stillman
Department of Radiology, University of Minnesota, Minneapolis 55455, USA.

PURPOSE: To determine the potential of proton MR spectroscopy to monitor patients with childhood-onset cerebral adrenoleukodystrophy (COCALD). METHODS: Single-voxel MR spectroscopy was performed in 16 children with COCALD (24 examinations) who had had no treatment and in 7 children (13 examinations) who had had bone marrow transplantation. RESULTS: In the untreated children with clinically active COCALD, the metabolite ratios N-acetyl-aspartate (NAA)/creatine (Cr) and NAA/choline (Ch) were decreased while Ch/Cr was increased. This trend agrees well with those reported by other researchers, although different experimental sequences and parameters were used in our study. Comparison of these ratios with those from a control group yielded significant differences in the occipital region. In the children who were clinically stable after bone marrow transplantation, the mean levels of the three ratios were between those of the control subjects and the patients with untreated COCALD: the differences in these ratios approached significance. In patients who had been monitored periodically, MR spectroscopy metabolite ratios correlated well with the dementia rating score, reflecting clinical status. CONCLUSION: There is good correlation between MR spectroscopy metabolite ratios and a patient's clinical status. MR spectroscopy appears to be a useful, noninvasive tool to monitor patients with adrenoleukodystrophy, and it increases the overall sensitivity of MR techniques in clinical applications.


This article has been cited by other articles:


Home page
RadioGraphicsHome page
J. H. Kim and H. J. Kim
Childhood X-linked Adrenoleukodystrophy: Clinical-Pathologic Overview and MR Imaging Manifestations at Initial Evaluation and Follow-up
RadioGraphics, May 1, 2005; 25(3): 619 - 631.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Oz, I. Tkac, L. R. Charnas, I. Y. Choi, K. J. Bjoraker, E. G. Shapiro, and R. Gruetter
Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients
Neurology, February 8, 2005; 64(3): 434 - 441.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
W. C. W. Chu, K.-w. Chik, Y.-l. Chan, D. K. W. Yeung, D. J. Roebuck, R. G. Howard, C.-k. Li, and C. Metreweli
White Matter and Cerebral Metabolite Changes in Children Undergoing Treatment for Acute Lymphoblastic Leukemia: Longitudinal Study with MR Imaging and 1H MR Spectroscopy
Radiology, December 1, 2003; 229(3): 659 - 669.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Fatemi, P.B. Barker, A.M. Ulug, L.M. Nagae-Poetscher, N.J. Beauchamp, A.B. Moser, G.V. Raymond, H.W. Moser, and S. Naidu
MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy
Neurology, April 22, 2003; 60(8): 1301 - 1307.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. S. Eichler, P. B. Barker, C. Cox, D. Edwin, A. M. Ulug, H. W. Moser, and G. V. Raymond
Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy
Neurology, March 26, 2002; 58(6): 901 - 907.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. K. Lim, C. H. Suh, H. J. Kim, Y. K. Cho, S. H. Choi, J. H. Kang, W. Park, and J. H. Lee
Systemic Lupus Erythematosus: Brain MR Imaging and Single-Voxel Hydrogen 1 MR Spectroscopy
Radiology, October 1, 2000; 217(1): 43 - 49.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
W. S. Ball Jr
PEDIATRIC NEURORADIOLOGY
AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 29 - 36.
[Full Text] [PDF]


Home page
NeurologyHome page
T. Varho, M. Komu, P. Sonninen, I. Holopainen, S. Nyman, T. Manner, M. Sillanpaa, P. Aula, and N. Lundbom
A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease
Neurology, May 1, 1999; 52(8): 1668 - 1668.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
I. Akiguchi, S. Nakano, A. Shiino, R. Kimura, T. Inubushi, J. Handa, M. Nakamura, M. Tanaka, N. Oka, and J. Kimura
Brain Proton Magnetic Resonance Spectroscopy and Brain Atrophy in Myotonic Dystrophy
Arch Neurol, March 1, 1999; 56(3): 325 - 330.
[Abstract] [Full Text] [PDF]